A detailed history of Imc Chicago, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 21,833 shares of ADMA stock, worth $339,721. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,833
Previous 27,606 20.91%
Holding current value
$339,721
Previous $502,000 36.25%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$14.66 - $19.91 $84,632 - $114,940
-5,773 Reduced 20.91%
21,833 $320,000
Q2 2025

Jul 22, 2025

BUY
$17.6 - $24.51 $485,865 - $676,623
27,606 New
27,606 $502,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.